Acupuncture and Herbal Medicine
|
2026, 6(1): 56-72
Oridonin mitigates cerebral ischemic-reperfusion injury via covalent binding to HMGB1 and inhibiting the HMGB1/TLR4/MyD88/NF-κB signaling pathway
Full
- 1State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
- 2School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- 3Department of Physiological Sciences, National University of Singapore, Singapore, Singapore
- 4National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China
Dandan Liu, Shujie Zhang, Fei Xia, Qiaoli Shi, Hui Zhao, Yinkwan Wong, Yuqing Meng, Yanqing Liu, Yongping Zhu, Xin Chai, Jiale Xing, Huan Tang, Chong Qiu, Peili Wang, Ang Ma, Jigang Wang.
Oridonin mitigates cerebral ischemic-reperfusion injury via covalent binding to HMGB1 and inhibiting the HMGB1/TLR4/MyD88/NF-κB signaling pathway[J].
Acupuncture and Herbal Medicine,
2026
, 6
(1)
: 56
-72
.
DOI: 10.1097/HM9.0000000000000181
- National Natural Science Foundation of China(82204672)
- Scientific and technological innovation project of China Academy of Chinese Medical Sciences(CI2023E002)
- Fundamental Research Funds for the Central Public Welfare Research Institutes(ZZ15-YQ-063)